| EMA number | EMEA/H/C/000431 |
| ATC code | M01AH03 |
| Authorisation | 27 March 2003 |
| Withdrawn | 27 March 2008 |
| Revision | 2 |
Symptomatic relief in the treatment of osteoarthritis or rheumatoid arthritis.Treatment of primary dysmenorrhoea. The decision to prescribe a selective COX-2 inhibitor should be based on an assessment of the individual patient's overall risk (see sections 4.3, 4.4).